Astute Medical specializes in advanced diagnostic solutions that address critical healthcare challenges, particularly in the areas of antimicrobial resistance, sepsis, and infectious diseases. Their product offerings include a range of innovative diagnostic tests such as the D-COUNT®, GENE-UP®, and VIDAS® systems, which are designed to provide rapid and accurate results for various medical conditions. These technologies enable healthcare professionals to make informed decisions quickly, improving patient outcomes and enhancing the efficiency of clinical workflows. The company emphasizes the importance of antimicrobial stewardship, particularly in emergency care settings, where their diagnostics can help optimize antibiotic use and combat the rising threat of antimicrobial resistance.

In addition to their diagnostic tests, Astute Medical also focuses on quality control solutions for the pharmaceutical and food safety industries. Their technologies, such as the TEMPO® system for quality indicator testing and the ENDONEXT™ assays for endotoxin detection, are designed to ensure the safety and efficacy of products across various sectors. By leveraging advanced molecular techniques and automated systems, Astute Medical aims to streamline processes and enhance the reliability of testing in both clinical and industrial environments. Their commitment to innovation and public health underscores their role as a leader in the field of in vitro diagnostics.

United States

Astute Medical is a healthcare company that specializes in identifying and validating unique biomarkers to rapidly assess high-risk acute conditions and diseases, supporting healthcare professionals with useful clinical tools.

Astute Medical

Company Details